Osteoporosis and Dental Implant

• Status: Unknown status
• Trial end date: 2010-04-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to evaluate the influence of alendronate therapy on the wound healing after dental implants in patients with osteoporosis.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Charite University, Berlin, Germany
• Treatments: Alendronate; Calcium, Dietary; Ergocalciferols; Vitamin D; Vitamins

Criteria

Inclusion Criteria:

• Postmenopausal women > 2 years after menopause

• Age between 60 and 75 years

• Possibility to insert a dental implant

• Osteoporosis as defined by WHO criteria (intervention group), or women without osteoporosis / osteopenia (non-intervention group)

Exclusion Criteria:

• Pathological findings in the jaw bone

• Chronic inflammatory rheumatoid disease

• Bisphosphonate treatments during the last 12 months

• Inflammatory or metabolic bone disease, excluding osteoporosis

• Systemic corticosteroid treatments of more than one month within previous 12 months

• Severe diseases with life expectancy less than one year or expectation of rapid worsening within one year